metformin vs semaglutide for weight loss vs. Ozempic: Which Drug Loss, Prediabetes, PCOS, and More Efficacy and safety of once‐weekly

Semaglutide (Wegovy) was tested in clinical trials and was found to help people lose an average of 21% of their starting weight after 72 weeks on the 7.2mg maintenance dose

In comparison, the STEP-1 trial reported that 2.4mg/weekly semaglutide led to side effects in 89.7% of the subjects, with the most common complaints being [17]: Nausea (44.2% of subjects) Diarrhea (31.5%) Vomiting (24.8%) Constipation (23.4%) Dyspepsia (10.3%) Abdominal pain (10% Gallbladder-related events (2.6%) The majority of gastrointestinal reactions were of mild to moderate intensity, temporary, and resolved without needing a permanent halt in treatment

A: GLP-1 agonist therapy is suitable for individuals struggling with obesity or those who have not achieved significant weight loss through diet and exercise alone

With the combination of my surgery and the support I received through MDWatch, I am now down to 156 pounds

Reducing the Risk of Adverse Effects Incorrectly mixed medication can lead to a range of adverse effects, from mild discomfort to more serious health issues